P Dejace
Overview
Explore the profile of P Dejace including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruhe J, Menon A, Mushatt D, Dejace P, Hasbun R
Eur J Clin Microbiol Infect Dis
. 2004 May;
23(6):495-8.
PMID: 15141334
In order to explore the clinical significance and risk factors for true bacteremia caused by coagulase-negative staphylococci (CNS) other than Staphylococcus epidermidis, a retrospective cohort study of 160 patients with...
2.
Love G, Dejace P, Arcement C
Clin Infect Dis
. 1993 Nov;
17(5):933-4.
PMID: 8286649
No abstract available.
3.
Richard V, Meunier F, Van der Auwera P, Dejace P, Daneau D, Klastersky J
Eur J Epidemiol
. 1988 Jun;
4(2):242-5.
PMID: 3402582
Twenty-eight episodes of Streptococcus pneumoniae bacteremia occurring in 27 cancer patients hospitalized in the Institut Jules Bordet between July 1979 and April 1985 were reviewed. Ten patients had hematological malignancies...
4.
[A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside]
Dejace P, Klastersky J
Infection
. 1987 Jan;
15 Suppl 4:S158-67.
PMID: 3312028
We have reviewed the available literature on the controlled use of combinations of beta-lactams in the treatment of fever in neutropenic patients, as compared to that of combinations of beta-lactams...
5.
6.
Dejace P, Klastersky J
Am J Med
. 1986 Jun;
80(6B):29-38.
PMID: 3524218
Febrile neutropenic patients are usually treated with a combination of a beta-lactam and an aminoglycoside. Since Pseudomonas aeruginosa is an important pathogen in these patients, the empiric use of possibly...
7.
Dejace P, Klastersky J
Eur J Clin Microbiol
. 1986 Feb;
5(1):58-60.
PMID: 3516685
No abstract available.
8.
Lagast H, Dejace P, Klastersky J
Eur J Clin Microbiol
. 1986 Feb;
5(1):98-102.
PMID: 3084248
To determine whether high doses of amikacin would prevent the development of resistance in clinical isolates, the serum bactericidal activity and killing rate of conventional and high doses of amikacin...
9.
Dejace P, Klastersky J
Scand J Infect Dis Suppl
. 1986 Jan;
49:165-71.
PMID: 3547622
Many authors in the literature have investigated the use of antibiotics in prophylaxis against infections in granulocytopenic patients. Two general methods have been used: one consists in trying to decontaminate...